Lv24
118 积分 2025-08-26 加入
Integrative multiomics analysis of nasal brushes illuminates systemic alterations of asthma-related genes
21小时前
求助中
A new anti-inflammatory treatment for bronchiectasis: a viewpoint on optimal dose selection for DPP1 inhibition in clinical practice
21小时前
求助中
The effects of a CXCR1/CXCR2 antagonist on neutrophil migration in mild atopic asthmatic subjects
3天前
已完结
WS19.05 A Phase II trial (CLAIRAFLY) to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of the dipeptidyl peptidase 1 inhibitor BI 1291583 in adults with bronchiectasis due to cystic fibrosis
5天前
已关闭
PRAGMA-CF. A Quantitative Structural Lung Disease Computed Tomography Outcome in Young Children with Cystic Fibrosis
6天前
已完结
Improvement in Lung Clearance Index and Chest Computed Tomography Scores with Elexacaftor/Tezacaftor/Ivacaftor Treatment in People with Cystic Fibrosis Aged 12 Years and Older – The RECOVER Trial
6天前
已完结
Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial
6天前
已完结
Mixed Sputum Granulocyte Longitudinal Impact on Lung Function in the Severe Asthma Research Program
7天前
已完结
Discovery of GS-2278, a Potent and Selective LPAR1 Antagonist for the Treatment of Idiopathic Pulmonary Fibrosis
9天前
已完结
IL-33, inflammation and mucus in COPD: the final FRONTIER?
10天前
已完结
皖公网安备34019202002308
